207 related articles for article (PubMed ID: 30826573)
1. Astragaloside IV inhibits palmitate-mediated oxidative stress and fibrosis in human glomerular mesangial cells via downregulation of CD36 expression.
Su Y; Chen Q; Ma K; Ju Y; Ji T; Wang Z; Li W; Li W
Pharmacol Rep; 2019 Apr; 71(2):319-329. PubMed ID: 30826573
[TBL] [Abstract][Full Text] [Related]
2. Palmitate induces human glomerular mesangial cells fibrosis through CD36-mediated transient receptor potential canonical channel 6/nuclear factor of activated T cell 2 activation.
Su Y; Chen Q; Ju Y; Li W; Li W
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Dec; 1865(12):158793. PubMed ID: 32800850
[TBL] [Abstract][Full Text] [Related]
3. Combination of Ginsenoside Rg1 and Astragaloside IV reduces oxidative stress and inhibits TGF-β1/Smads signaling cascade on renal fibrosis in rats with diabetic nephropathy.
Du N; Xu Z; Gao M; Liu P; Sun B; Cao X
Drug Des Devel Ther; 2018; 12():3517-3524. PubMed ID: 30425453
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of NADPH Oxidase 5 (NOX5) Suppresses High Glucose-Induced Oxidative Stress, Inflammation and Extracellular Matrix Accumulation in Human Glomerular Mesangial Cells.
Li Y; Li Y; Zheng S
Med Sci Monit; 2020 Feb; 26():e919399. PubMed ID: 32012145
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV improves renal function and fibrosis via inhibition of miR-21-induced podocyte dedifferentiation and mesangial cell activation in diabetic mice.
Wang X; Gao Y; Tian N; Zou D; Shi Y; Zhang N
Drug Des Devel Ther; 2018; 12():2431-2442. PubMed ID: 30122901
[TBL] [Abstract][Full Text] [Related]
6. AST IV inhibits H₂O₂-induced human umbilical vein endothelial cell apoptosis by suppressing Nox4 expression through the TGF-β1/Smad2 pathway.
Ma Y; Li W; Yin Y; Li W
Int J Mol Med; 2015 Jun; 35(6):1667-74. PubMed ID: 25891879
[TBL] [Abstract][Full Text] [Related]
7. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
[TBL] [Abstract][Full Text] [Related]
8. Astaxanthin Promotes Nrf2/ARE Signaling to Inhibit HG-Induced Renal Fibrosis in GMCs.
Xie X; Chen Q; Tao J
Mar Drugs; 2018 Apr; 16(4):. PubMed ID: 29621130
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rg1 attenuates glomerular fibrosis by inhibiting CD36/TRPC6/NFAT2 signaling in type 2 diabetes mellitus mice.
Han Y; Su Y; Han M; Liu Y; Shi Q; Li X; Wang P; Li W; Li W
J Ethnopharmacol; 2023 Feb; 302(Pt A):115923. PubMed ID: 36375645
[TBL] [Abstract][Full Text] [Related]
10. Astragaloside IV prevents damage to human mesangial cells through the inhibition of the NADPH oxidase/ROS/Akt/NF‑κB pathway under high glucose conditions.
Sun L; Li W; Li W; Xiong L; Li G; Ma R
Int J Mol Med; 2014 Jul; 34(1):167-76. PubMed ID: 24718766
[TBL] [Abstract][Full Text] [Related]
11. Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating Sirt1 to resist AGEs-induced upregulation of fibronetin and transforming growth factor-β1 in rat glomerular messangial cells.
Huang K; Chen C; Hao J; Huang J; Wang S; Liu P; Huang H
Mol Cell Endocrinol; 2015 Jan; 399():178-89. PubMed ID: 25192797
[TBL] [Abstract][Full Text] [Related]
12. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells.
Huang K; Huang J; Xie X; Wang S; Chen C; Shen X; Liu P; Huang H
Free Radic Biol Med; 2013 Dec; 65():528-540. PubMed ID: 23891678
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV Synergizes with Ferulic Acid to Alleviate Hepatic Fibrosis in Bile Duct-Ligated Cirrhotic Rats.
Zhao XM; Zhang J; Liang YN; Niu YC
Dig Dis Sci; 2020 Oct; 65(10):2925-2936. PubMed ID: 31900718
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress.
Wang ZS; Xiong F; Xie XH; Chen D; Pan JH; Cheng L
BMC Nephrol; 2015 Mar; 16():44. PubMed ID: 25886386
[TBL] [Abstract][Full Text] [Related]
15. WJ-39, an Aldose Reductase Inhibitor, Ameliorates Renal Lesions in Diabetic Nephropathy by Activating Nrf2 Signaling.
Zhou X; Liu Z; Ying K; Wang H; Liu P; Ji X; Chi T; Zou L; Wang S; He Z
Oxid Med Cell Longev; 2020; 2020():7950457. PubMed ID: 32566101
[TBL] [Abstract][Full Text] [Related]
16. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress.
Liu J; Yang P; Zuo G; He S; Tan W; Zhang X; Su C; Zhao L; Wei L; Chen Y; Ruan X; Chen Y
Lipids Health Dis; 2018 Jul; 17(1):153. PubMed ID: 30016988
[TBL] [Abstract][Full Text] [Related]
17. CD36 Mediated Fatty Acid-Induced Podocyte Apoptosis via Oxidative Stress.
Hua W; Huang HZ; Tan LT; Wan JM; Gui HB; Zhao L; Ruan XZ; Chen XM; Du XG
PLoS One; 2015; 10(5):e0127507. PubMed ID: 26000608
[TBL] [Abstract][Full Text] [Related]
18. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
[TBL] [Abstract][Full Text] [Related]
19. Valsartan attenuated oxidative stress, decreased MCP-1 and TGF-β1 expression in glomerular mesangial and epithelial cells induced by high-glucose levels.
Jiao B; Wang YS; Cheng YN; Gao JJ; Zhang QZ
Biosci Trends; 2011 Aug; 5(4):173-81. PubMed ID: 21914953
[TBL] [Abstract][Full Text] [Related]
20. miR-485 suppresses inflammation and proliferation of mesangial cells in an in vitro model of diabetic nephropathy by targeting NOX5.
Wu J; Lu K; Zhu M; Xie X; Ding Y; Shao X; Chen Y; Liu J; Xu M; Xu Y; Zhou J; Shen X; Zhu C
Biochem Biophys Res Commun; 2020 Jan; 521(4):984-990. PubMed ID: 31727371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
